Skip to main content
IL-1 blockade as a novel approach to treatment of hyperzincemia and hypercalprotectinemia, a possible new autoinflammatory syndrome.
Long-term education and employment outcomes in pediatric-onset systemic lupus erythematosus.
Improving transition readiness and quality of life (QOL) with a pediatric lupus health passport.